Clinical trial
Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin…
NCT00004286 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004286 |
|---|---|
| Title | Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | University of Vermont |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating |
| Intervention type | Drug |
| Interventions | immune globulin |
| Enrollment | 120 |
| Start date | Feb 1, 1996 |
| Completion | Nov 1, 1999 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: